Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05867446
Other study ID # 2023/ 04- 12
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date April 12, 2023
Est. completion date December 28, 2023

Study information

Verified date June 2023
Source Ataturk University
Contact Gülcan B.TURAN, PHD
Phone 05065576086
Email glcnbah@hotmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Hemodialysis complex treatment regimen includes fluid and diet management. In this context, it is recommended that patients choose foods with low sodium, potassium and phosphorus content, maintain adequate protein intake, and regulate their daily fluid intake not exceeding 1-2 liters. In maintaining the health of hemodialysis patients; It is very important that they comply with the treatment program, diet and fluid restrictions. As the life expectancy increases, the time spent with chronic disease also increases, and both the patient himself and his relatives living in the same house are faced with this chronic disease and accompanying stress factors for a longer period of time, making it difficult for them to adapt to the progression of the disease. Pecha Kucha (PK), meaning "chat voice" or "chat" in Japanese, refers to a well-crafted, fast and concise presentation format. In a PK presentation, each presenter is only allowed to show 20 PowerPoint slides for 20 seconds each on a timer. When the literature was examined, no study was found that evaluated the effect of the education given to hemodialysis patients with the Pecha Kuka method on the attitude towards diet therapy and compliance with fluid restriction. In addition, it is thought that this short and concise education method will contribute to a better understanding of the attitudes of patients receiving hemodialysis treatment towards diet therapy and their compliance with fluid restriction, thus providing important data for future studies.


Description:

Diet is one of the most important elements of HD treatment. Kidney disease can be slowed down with diet. There are important issues in the diet of individuals receiving HD treatment. Adequate energy consumption comes first. Individuals receiving HD treatment must meet the energy requirements needed to maintain their health, as well as perform their metabolic functions. Adequate protein intake is one of the important issues in the diet in patients receiving HD treatment. Compliance with disease treatment; it is briefly defined as "individual compliance with medical treatment and health recommendations". During the period of hemodialysis treatment, one of the areas where individuals have difficulty in adapting is diet and fluid restriction. Because the disease and HD treatment directly affect the eating habits and preferences of individuals. As with all chronic diseases, it is very important for individuals who continue HD treatment to comply with the drug treatment program, diet and fluid restrictions in order to maintain their health. refers to a fast and concise presentation format. It was created in 2003 by architects Astrid Klein and Mark Dytham, who hoped to give young designers the opportunity to present their work in a short, fast-paced setting. In a PK presentation, each presenter is only allowed to show 20 PowerPoint slides for 20 seconds each on a timer. In other words, the presenter has only 20 seconds to discuss each slide before the next slide appears, and the presentation time is limited to 6 minutes and 40 seconds. Ideas are explained visually with pictures and graphics, and there is little text on the slides.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date December 28, 2023
Est. primary completion date September 30, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - The patient does not have any impairment (such as vision, speech and hearing) that prevents him from communicating. - Accepting the research - Being receiving hemodialysis treatment - Ability to communicate adequately - Absence of psychiatric problems Exclusion Criteria: -

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
pecha kucha
pecha kucha training

Locations

Country Name City State
Turkey Gülcan B Turan Elazig Merkez

Sponsors (1)

Lead Sponsor Collaborator
Ataturk University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Attitude Scale Towards Dietary Treatment of Hemodialysis Patients "Attitude Scale Towards Dietary Treatment of Hemodialysis Patients" is a 16-item scale developed by Onbe and Kanda in 2018 to determine the attitudes of patients towards diet therapy. It is a 4 likert scale.
Each item represents 1-Strongly agree, 2-Agree, 3-Disagree, 4-Strongly Disagree. This scale consists of 3 sub-dimensions.
Sub size; "Behavioral tendency affected by cognition" includes 7 items (1,2,3,4,5,6,7).
Sub-dimension; "Behavioral tendency affected by food culture" includes 6 (8,9,10,11,12,13) items.
Sub-dimension; "Negative effect that changes diet" includes 3 items (14,15,16). The last three items in the scale are reversed.
Higher scores obtained from the scale indicate that attitudes are better. Effect on Retention and Fluid Restriction Compliance
1 hours later
Primary Dialysis Diet and Fluid Restriction Compliance Scale It was developed by Vlaminck et al. (2001), and its Turkish validity and reliability study was performed by Kara (2009) in hemodialysis patients. WHO is a four-item self-report tool used to evaluate non-adherence to diet and fluid intake restriction in hemodialysis patients. Two items in the scale deal with diet (items 1 and 2), and the other two deal with fluid restriction (items 3 and 4) in terms of frequency and degree. The frequency of non-compliance with diet and fluid restriction is based on the behaviors of the patients in the previous 14 days. The degree of non-compliance with diet and fluid restriction has a Likert-type structure scored between 0-4 (No non-compliance = 0, Mild = 1, Moderate = 2, Severe = 3, Very severe =4) The Cronbach alpha coefficient of the scale was reported as 0.70. 1 hours later
See also
  Status Clinical Trial Phase
Active, not recruiting NCT06382701 - Effect of Aromatherapy on Pain, Anxiety and Satisfaction in Cannulation N/A
Completed NCT04674930 - Effects of Exercise Program on Physical Functioning of Hemodialysis Patients. N/A
Recruiting NCT02245633 - Correlation Between Vitamin D Levels to ADAMTS13 , VWF and Micro RNA Expression in Diabetic Hemodialysis Patients N/A
Recruiting NCT01970280 - Low Molecular Weight Heparin in Prevention of Recurrent Arteriovenous Graft Thrombosis in Chronic Hemodialysis Patients. Phase 4
Completed NCT06165211 - Nature-Based Sound Application For Hemodialysis Patients N/A
Completed NCT05693584 - The Effect of Using Virtual Reality Glasses on Pain During Fistula Cannulation in Hemodialysis Patients N/A
Completed NCT06106763 - Mandala Colouring On Anxiety, Depression, Pain And Quality of Life N/A
Completed NCT01932853 - Association Between Dose Dialysis by Kt and Mortality N/A
Completed NCT01273974 - The Immunogenicity of Intradermal Influenza Vaccination in Hemodialysis Patients Phase 2/Phase 3
Completed NCT04139759 - THE EFFECT OF HAND AND FOOT MASSAGE ON FATIGUE IN HEMODIALYSIS PATIENTS N/A
Not yet recruiting NCT05574595 - Effect on Pain and Comfort Associated With Fistula Puncture N/A
Completed NCT04175652 - Effects of Laughter Yoga on Hemodialysis Patients' Plasma-Beta Endorphin Levels, Pain Levels and Sleep Quality N/A
Not yet recruiting NCT06314243 - The Impact of Pumpkin Seed Oil Supplementation on Hemodialysis Patients Phase 3
Completed NCT01596842 - Effect of Omega-3 Fatty Acid on Vitamin D Activation Phase 4
Enrolling by invitation NCT01896882 - Dietary Sodium Restriction in Hemodialysis Patients N/A
Completed NCT00638300 - Removal of Ligand-bound Iron During Intravenous (IV) Iron Administration in Hemodialysis (HD) N/A
Terminated NCT00259714 - Dialysate Sodium Individualization in Hemodialysis Phase 1
Completed NCT01846754 - Prevalence of Fatigue in Hemodialysis Patients N/A
Completed NCT00491868 - Clinical Study of R744 to Hemodialysis Patients Phase 3
Completed NCT04195919 - The Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of Evogliptin in Hemodialysis Patients Phase 1